LC-MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity.

6-methylmercaptopurine 6-thioguanine clinical evaluation mass spectromerty thiopurine methyl transferase

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2021
accepted: 14 02 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Monitoring concentrations of thiopurine metabolites is used clinically to prevent adverse effects in patients on thiopurine drug therapy. We developed a LC-MS/MS method for the quantification of 6-thioguanine (6-TG) and 6-methylmercaptopurine (6-MMP) in red blood cells (RBCs). This method utilizes an automated cell washer for RBC separation from whole blood samples and washing of the separated RBCs. The lower limit of quantification of the method was 0.2 μmol/L for 6-TG (∼50 pmol/8 × 10

Identifiants

pubmed: 35387339
doi: 10.3389/fphar.2022.836812
pii: 836812
pmc: PMC8978547
doi:

Types de publication

Journal Article

Langues

eng

Pagination

836812

Informations de copyright

Copyright © 2022 Bajaj, Kushnir, Kish-Trier, Law, Zuromski, Molinelli, McMillin and Johnson-Davis.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Pharm Biomed Anal. 2013 Mar 5;75:145-52
pubmed: 23261807
Am J Hematol. 1984 Aug;17(2):177-83
pubmed: 6465134
Anal Chem. 2012 Feb 7;84(3):1294-301
pubmed: 22220820
Clin Biochem. 2005 Apr;38(4):319-27
pubmed: 15766733
Blood. 1998 Nov 15;92(10):3569-77
pubmed: 9808549
Nat Genet. 2016 Apr;48(4):367-73
pubmed: 26878724
J Chromatogr. 1982 Sep 10;231(2):393-9
pubmed: 6890068
Clin Chem. 1998 Mar;44(3):551-5
pubmed: 9510860
Clin Chem. 2008 Jan;54(1):216-8
pubmed: 18160731
J Appl Lab Med. 2019 Mar;3(5):827-838
pubmed: 31639757
Clin Chem. 2003 Feb;49(2):260-8
pubmed: 12560349
Ther Drug Monit. 2013 Jun;35(3):313-21
pubmed: 23666567
Ann Lab Med. 2018 May;38(3):255-260
pubmed: 29401561
Blood. 1992 Jan 1;79(1):254-60
pubmed: 1728314
J Pharm Biomed Anal. 2017 Oct 25;145:758-764
pubmed: 28818801
Clin Gastroenterol Hepatol. 2005 Oct;3(10):1007-14
pubmed: 16234047
J Clin Gastroenterol. 2021 Mar 1;55(3):195-206
pubmed: 32740098
Gut. 2003 Jan;52(1):140-2
pubmed: 12477776
Braz J Med Biol Res. 2004 May;37(5):649-58
pubmed: 15107925
Clin Gastroenterol Hepatol. 2004 May;2(5):410-7
pubmed: 15118980
Expert Opin Drug Metab Toxicol. 2021 Oct;17(10):1187-1198
pubmed: 34452592
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):435-44
pubmed: 22697075
Clin Chem. 1965 Aug;11:771-81
pubmed: 14319233
Ther Drug Monit. 2017 Dec;39(6):584-588
pubmed: 29040228
Clin Pharmacol Ther. 2019 May;105(5):1095-1105
pubmed: 30447069
Rev Gastroenterol Disord. 2009 Summer;9(3):E69-77
pubmed: 19898267
Science. 1996 Aug 23;273(5278):1109-11
pubmed: 8688098
J Chromatogr. 1992 Nov 27;583(1):83-90
pubmed: 1484095
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 1;1038:88-94
pubmed: 27802917
Clin Pharmacol Ther. 2011 Mar;89(3):387-91
pubmed: 21270794
J Clin Oncol. 2015 Apr 10;33(11):1235-42
pubmed: 25624441
Eur J Cancer. 2005 Mar;41(4):613-23
pubmed: 15737567
J Biol Chem. 1994 Jan 28;269(4):2399-404
pubmed: 8300565
Br J Clin Pharmacol. 2014 Apr;77(4):704-14
pubmed: 23962279
Clin Pharmacol Ther. 1997 Oct;62(4):464-75
pubmed: 9357398
Br J Clin Pharmacol. 2001 Nov;52(5):539-46
pubmed: 11736862
Anal Biochem. 1985 Feb 1;144(2):514-21
pubmed: 4039541
Ther Drug Monit. 2019 Feb;41(1):75-85
pubmed: 30507626
Clin Chem. 2005 Nov;51(11):2074-84
pubmed: 16166171
Pharmacogenetics. 2002 Aug;12(6):429-36
pubmed: 12172211
Clin Pharmacol Ther. 2004 Apr;75(4):274-81
pubmed: 15060506
Bioimpacts. 2011;1(1):53-62
pubmed: 23678408
Biomed Chromatogr. 1990 Mar;4(2):47-51
pubmed: 2350596
Nat Rev Cancer. 2008 Jan;8(1):24-36
pubmed: 18097462
J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57
pubmed: 16048561
J Clin Oncol. 2001 Apr 15;19(8):2293-301
pubmed: 11304783
J Chromatogr B Biomed Sci Appl. 2001 Jun 5;757(1):1-9
pubmed: 11419732

Auteurs

Amol O Bajaj (AO)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.

Mark M Kushnir (MM)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
University of Utah Health Sciences Center, Department of Pathology, Salt Lake City, UT, United States.

Erik Kish-Trier (E)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.

Rachel N Law (RN)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.

Lauren M Zuromski (LM)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.

Alejandro R Molinelli (AR)

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States.

Gwendolyn A McMillin (GA)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
University of Utah Health Sciences Center, Department of Pathology, Salt Lake City, UT, United States.

Kamisha L Johnson-Davis (KL)

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
University of Utah Health Sciences Center, Department of Pathology, Salt Lake City, UT, United States.

Classifications MeSH